A Double-Blind, Randomized, Placebo-and Active-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Subjects With Osteoarthritis.
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2012
At a glance
- Drugs Mavatrep; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 21 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 21 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Dec 2011 Actual patient number reported as 43 by ClinicalTrials.gov.